The amount of bleeding during rhinoplasty surgery. Follow-up care involving plastic surgery of head and neck
Conditions
Interventions
Intervention 1: Intervention group: receiving dexmedetomidine with a loading dose of 1.0-0.5 µg/kg and a maintenance dose (0.5-0.3 µg/kg/h) and remifentanil with a maintenance dose (0.5-0.25 mcg/kg/mi
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Rhinoplasty surgery candidate No history of nose surgery Not suffering from chronic and severe diseases (diabetes, high blood pressure, cancer, etc.) patients with physical class higher than 2
Exclusion criteria
Exclusion criteria: Patients with systolic blood pressure less than 100 mm Hg Heart rate less than 60 per minute Patients with relative or absolute prohibition of general anesthesia Patients with chronic drug or alcohol use Specific use of any interfering drug during anesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding volume. Timepoint: After the operation is completed. Method of measurement: Calculating the amount of blood in the suction, sterile gases and the surgeon's satisfaction with the surgical field.;Blood pressure. Timepoint: Before the operation, 15-30-45 minutes after the start of the intervention and the end of the operation. Method of measurement: By monitoring the patient's vital signs.;Heart rate. Timepoint: Before the operation, 15-30-45 minutes after the start of the intervention and the end of the operation. Method of measurement: By monitoring the patient's vital signs. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElnaz Rahmani
Kerman University of Medical Sciences
Outcome results
None listed